Cramer's Morning Take: Bristol Meyers 2/6/25

Jim and Jeff discuss the profit guidance for this pharmaceutical stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer